Entera Bio Ltd. (ENTX) earnings date
Mar 26, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 67% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 39 days, typically, give or take 22 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Fri, Nov 6, 2026 | after close | 37 | 8-K |
| Q2 FY2026 | Fri, Aug 7, 2026 | after close | 38 | 8-K |
| Q1 FY2026 | Fri, May 8, 2026 | after close | 38 | 8-K |
| Q4 FY2025 | Fri, Mar 27, 2026 | after close | 86 | 8-K |
| Q3 FY2025 | Fri, Nov 14, 2025 | after close | 45 | 8-K |
| Q2 FY2025 | Fri, Aug 8, 2025 | after close | 39 | 8-K |
| Q1 FY2025 | Fri, May 9, 2025 | after close | 39 | 8-K |
| Q4 FY2024 | Fri, Mar 28, 2025 | after close | 87 | 8-K |
What they guided beta
| Q3 FY2026 | "Clinical Preparations Advanced for EB613 Phase 3 Osteoporosis Study, with First Site Activation Expected in Late 2026" exhibit |
| Q3 FY2026 | "Our team is fully focused on ensuring a seamless trial launch, with expected first site activation in late 2026." exhibit |
| Q3 FY2026 | "Additionally, the post-hoc analysis that we presented at ASBMR 2026 demonstrated that our Phase 2 6-month clinical data with EB613 show rapid stimulation of bone formation and robust early bone mineral density (BMD) accrual, especially in patients who start with lower BMD and who need the largest gains." exhibit |
| Q3 FY2026 | "The Company’s cash resources are expected to be sufficient to fully fund the planned Phase 3 registrational program of EB613 through topline results and the anticipated submission of an NDA to the FDA and to support the Company’s operations into 2030." exhibit |
| Q2 FY2026 | "On a pro forma basis, following the closing of the July 2026 private placement in which the Company received aggregate gross proceeds of approximately $275.0 million, the Company’s cash resources are expected to be sufficient to fully fund the planned Phase 3 registrational program of EB613 through topline results and the anticipated submission of an NDA to the FDA and to support the Company’s operations into 2030." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ENTX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ENTX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/ENTX/"><img src="https://veritasdata.dev/embed/ENTX.svg" alt="ENTX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/ENTX/)
Script
<script async src="https://veritasdata.dev/embed/ENTX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ENTX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.